Protein Microarrays Market by Offering (Products, Services), Type (Biochips, Microarray Instruments), Application (Clinical, Drug Discovery) - Global Forecast to 2030

icon1
USD 1.78
MARKET SIZE, 2030
icon2
CAGR 12.3%
(2025-2030)
icon3
781
REPORT PAGES
icon4
983
MARKET TABLES

OVERVIEW

protein-microarrays-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The protein microarrays market is projected to reach USD 1.78 billion by 2030 from USD 1.00 billion in 2025, at a CAGR of 12.3% from 2025 to 2030, supported by advances in multiplexing, automation, and bioinformatics. These advancements enable parallel analysis of protein interactions, biomarkers, and functional assays, providing deeper insights into disease biology and therapeutic response for oncology, neurology, and immunology applications.

KEY TAKEAWAYS

  • By Region
    By region, the microarrays market in North America is projected to register the highest CAGR of 12.4% from 2025 to 2030.
  • By Offering
    By offering, the products segment is expected to dominate the market during the forecast period.
  • By Type
    By type, the biochips segment is projected to grow at a faster rate than the microarray instruments segment during the forecast period.
  • By End User
    By end user, biopharmaceutical companies are estimated to dominate the protein microarrays market.
  • COMPETITIVE LANDSCAPE
    Thermofisher Scientific Inc (US), Danaher Corporation (US), and Agilent Technologies (US) were identified as some of the star players in the protein microarrays market, given their strong market share and product footprint.
  • COMPETITIVE LANDSCAPE
    Pixelgen Technologies AB (Sweden) and MSAID GmbH (Germany), among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The protein microarrays market is expanding steadily, supported by surging biopharma investments, expanding academic-clinical collaborations, and rising adoption of protein microarrays for biomarker validation. Advanced protein microarray platforms empower researchers and clinicians to decode protein signaling networks, accelerate companion diagnostic development, and optimize immunotherapy response prediction.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The protein microarrays market is being reshaped by fast-moving scientific, regulatory, and clinical trends, set to intensify over the forecast period. Expanding applications in precision oncology, immunology, and neurodegenerative diseases, alongside surging clinical trial integration, are driving demand for multiplexed, reproducible platforms in diagnostics and biopharma R&D labs.

protein-microarrays-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • High-throughput biomarker discovery needs
  • Integration with multi-omics workflows
RESTRAINTS
Impact
Level
  • Technical complexity and requirement for expertise
OPPORTUNITIES
Impact
Level
  • Growing clinical diagnostics and prognostics adoption
CHALLENGES
Impact
Level
  • Data interpretation complexity

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: High-throughput biomarker discovery needs

Protein microarrays enable simultaneous analysis of thousands of proteins, making them highly valuable for biomarker identification in disease research, drug development, and immunoprofiling.

Restraint: Technical complexity and requirement for expertise

Successful execution and interpretation of protein microarrays require trained personnel and rigorous quality control, which can be barriers for widespread deployment.

Opportunity:Growing clinical diagnostics and prognostics adoption

Increasing clinical interest in protein signatures for early disease diagnosis refers to how there is a rising level of detection, therapeutic monitoring, and immunoprofiling support.

Challenge: Data interpretation complexity

The protein microarray data is huge and of higher dimensionality, requiring sophisticated bioinformatic analysis and statistical capabilities.

PROTEIN MICROARRAYS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Provides protein and antibody microarray platforms, functional protein arrays, detection reagents, and imaging systems used for high-throughput biomarker discovery, immune profiling, and pathway analysis in academic, CRO, and biopharma research settings. Enables simultaneous profiling of hundreds to thousands of proteins, accelerates biomarker discovery, reduces sample volume requirements, and supports translational and early clinical research programs.
Offers microarray fabrication technologies, array scanners, and surface chemistries that support custom and commercial protein and antibody microarrays for discovery and translational research applications. Delivers high sensitivity, flexible array design, and robust data quality, allowing laboratories to tailor protein panels to specific disease or pathway-focused studies.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The protein microarrays market involves the array platform vendors, reagents, bioinformatics tools, contract research organizations, biopharma firms, and clinical labs. There are vendors offering multiplexed protein, antibody array platforms, as well as sophisticated data analysis tools, whereas contract research organizations, core centers, or institutions perform HT, HP protein profiling analyses. This way, biopharma firms, hospitals, or healthcare centers can effectively isolate and validate protein biomarkers, which is further accompanied by high degrees of reproducibility and sensitivity, so protein-based findings can be translated into precision diagnostics, drugs, etc.

protein-microarrays-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

protein-microarrays-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Protein Microarrays Market, By Offering

By offering, the products segment accounted for the largest market share in 2024, fueled by widespread demand for standardized kits, array slides, and integrated scanners that streamline high-plex protein profiling over bespoke services.

Protein Microarrays Market, By Type

By type, the biochips segment held the major market share in 2025, leveraging their superior multiplexing capabilities, miniaturized high-density arrays, and compatibility with automated scanners to enable simultaneous detection of thousands of protein interactions for biomarker discovery and diagnostics.

Protein Microarrays Market, By Application

By application, the clinical diagnostics segment commanded the largest market share in 2024, powered by demand for multiplexed biomarker panels enabling rapid disease profiling, therapy monitoring, and personalized treatment selection in oncology, autoimmune disorders, and infectious diseases.

Protein Microarrays Market, By End User

Among end users, biopharmaceutical companies held the largest market share in 2024, leveraging multiplexed arrays for accelerated drug target validation, antibody screening, and biomarker discovery to streamline personalized medicine pipelines and reduce R&D timelines.

REGION

Asia Pacific to be fastest-growing region in protein microarrays market during forecast period

By region, the Asia Pacific protein microarrays market is projected to witness the highest growth rate due to rising biomarker demand, microarray technology advancements, biotech research investments, expanding pharma sectors, healthcare needs amid chronic diseases, and supportive government policies in China and India.

protein-microarrays-market Region

PROTEIN MICROARRAYS MARKET: COMPANY EVALUATION MATRIX

In the protein microarrays market matrix, Thermo Fisher Scientific(Star Player) dominates the widely adopted multiplex array platforms, high-density biochips, and integrated analysis software, anchoring major biopharma, CRO, and academic workflows. Agilent Technologies is an emerging leader. It gains in share through advanced protein profiling arrays and automation solutions that support biomarker discovery and translational applications. Niche protein interaction and multi-omics arrays from smaller specialist firms add competitive momentum and are well-placed for entry into the leaders' quadrant over time.

protein-microarrays-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 0.93 Billion
Market Forecast in 2030 (Value) USD 1.78 Billion
Growth Rate CAGR of 12.3% from 2025 to 2030
Years Considered 2023-2030
Base Year 2024
Forecast Period 2025-2030
Units Considered Value (USD Million)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Offering:
    • Products
    • Services
  • By Type:
    • Biochips
    • Microarray Instruments
  • By Application:
    • Clinical Diagnostics
    • Drug Discovery & Development
    • Other Applications
  • By End User:
    • Biopharmaceutical Companies
    • Academic Institutes & Research Institutes
    • Hospitals
    • Clinical Laboratories
    • Other End Users
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: PROTEIN MICROARRAYS MARKET REPORT CONTENT GUIDE

protein-microarrays-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Workflow standardization & scalability Benchmarked sample preparation protocols, assay reproducibility, inter-lot consistency, and scalability across academic, CRO, and biopharma environments. Supports development of standardized, scalable offerings suitable for multi-site studies and translational research programs.
Data analytics & interpretation readiness Evaluated availability and maturity of array data-processing software, normalization pipelines, and integration with bioinformatics and multi-omics platforms. Enables vendors and service providers to strengthen analytics capabilities and reduce barriers to customer adoption.

RECENT DEVELOPMENTS

  • October 2025 : Merck (Sigma-Aldrich) launched the Panorama Human Cancer Version 1 Protein Functional Microarray, enhancing high-throughput cancer biomarker screening and protein interaction studies with improved sensitivity for clinical research.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
 
4
MARKET OVERVIEW
Presents a concise view of industry direction, strategic priorities, and key indicators influencing market momentum.
 
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNTIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
5
INDUSTRY TRENDS
Provides a snapshot of current market scenario, value chain context, and factors impacting competitive intensity.
 
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
5.2.3
TRENDS IN THE PROTEIN MICROARRAYS MARKET
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PROTEOMICS INSTRUMENTS (2022-2025)
 
 
 
 
 
5.5.2
AVERAGE SELLING PRICE TREND, BY COUNTRY (2022-2025)
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
5.6.1
IMPORT SCENARIO (HS CODE 902720 AND 902781)
 
 
 
 
 
5.6.2
EXPORT SCENARIO (HS CODE 902720 AND 902781)
 
 
 
 
5.7
KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
5.9
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
 
 
 
 
5.10
IMPACT OF 2025 US TARIFF – PROTEIN MICROARRAY MARKET
 
 
 
 
 
 
 
5.10.2
INTRODUCTION
 
 
 
 
 
5.10.2
KEY TARIFF RATES
 
 
 
 
 
5.10.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
5.10.4
IMPACT ON COUNTRIES
 
 
 
 
 
 
5.10.4.1
NORTH AMERICA
 
 
 
 
 
5.10.4.2
EUROPE
 
 
 
 
 
5.10.4.3
APAC
 
 
 
 
5.10.5
IMPACT ON END-USE INDUSTRIES
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
6.1.1
MASS SPECTROMETRY
 
 
 
 
 
6.1.2
CHROMATOGRAPHY
 
 
 
 
 
6.1.3
PROTEIN MICROARRAYS
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
6.2.1
TRANSCRIPTOMICS
 
 
 
 
 
6.2.2
METABOLOMICS
 
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
6.3.1
SINGLE CELL PROTEOMICS
 
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
 
6.7
IMPACT OF AI/GEN AI ON PROTEIN MICROARRAY MARKET
 
 
 
 
 
 
 
6.7.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
6.7.2
CASE STUDIES OF AI IMPLEMENTATION IN THE PROTEIN MICROARRAY MARKET
 
 
 
 
 
6.7.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
6.7.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE PROTEIN MICROARRAY MARKET
 
 
 
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
 
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
 
 
 
 
 
7.3
CERTIFICATIONS, LABELING, ECO-STANDARDS
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
9
PROTEIN MICROARRAY MARKET, BY OFFERINGS, 2023-2030 (USD MILLION)
 
 
 
 
 
 
COMPARATIVE ASSESSMENT OF KEY PRODUCTS, THEIR MARKET POTENTIAL, AND REVENUE TRENDS
 
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
 
9.2
PRODUCTS
 
 
 
 
 
9.3
SERVICES
 
 
 
 
10
PROTEIN MICROARRAY MARKET, BY TYPE, 2023-2030 (USD MILLION)
 
 
 
 
 
 
COMPARATIVE ASSESSMENT OF KEY PRODUCTS, THEIR MARKET POTENTIAL, AND REVENUE TRENDS
 
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
 
10.2
BIOCHIPS
 
 
 
 
 
 
10.2.1
LAB-ON-CHIPS
 
 
 
 
 
10.2.2
PROTEIN CHIPS
 
 
 
 
10.3
MICROARRAY INSTRUMENTS
 
 
 
 
 
 
10.3.1
INTEGRATED SYSTEMS
 
 
 
 
 
10.3.2
ARRAYERS
 
 
 
11
PROTEIN MICROARRAY MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
 
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
 
11.2
CLINICAL DIAGOSTICS
 
 
 
 
 
 
11.2.1
CANCER
 
 
 
 
 
11.2.2
INFECTIOUS DISEASES
 
 
 
 
 
11.2.3
DIABETES
 
 
 
 
 
11.2.4
NEUROLOGICAL DISORDERS
 
 
 
 
 
11.2.5
AUTOIMMUNE DISEASES
 
 
 
 
 
11.2.6
CARDIOVASCULAR DISEASES
 
 
 
 
 
11.2.7
OTHER CLINICAL DIAGNOSTIC APPLICATIONS
 
 
 
 
11.3
DRUG DISCOVERY & DEVELOPMENT
 
 
 
 
 
 
11.3.1
TARGET DISCOVERY
 
 
 
 
 
11.3.2
LEAD IDENTIFICATION
 
 
 
 
 
11.3.3
LEAD OPTIMIZATION
 
 
 
 
 
11.3.4
PRECLINICAL STUDIES
 
 
 
 
11.4
OTHER APPLICATIONS
 
 
 
 
12
PROTEIN MICROARRAY MARKET, BY END USER, 2023-2030 (USD MILLION)
 
 
 
 
 
 
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS AND MARKET POTENTIAL ACROSS EACH END-USE INDUSTRY
 
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
 
12.2
BIOPHARMACEUTICAL COMPANIES
 
 
 
 
 
12.3
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
12.4
HOSPITALS
 
 
 
 
 
12.5
CLINICAL LABORATORIES
 
 
 
 
 
12.6
OTHER END USERS
 
 
 
 
13
PROTEIN MICROARRAY MARKET, BY REGION, 2023-2030 (USD MILLION)
 
 
 
 
 
 
ASSESSMENT OF GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY GEOGRAPHIES AND COUNTRIES
 
 
 
 
 
 
13.1
INTRODUCTION
 
 
 
 
 
13.2
NORTH AMERICA
 
 
 
 
 
 
13.2.1
US
 
 
 
 
 
13.2.2
CANADA
 
 
 
 
 
13.2.3
MACROECONOMIC OUTLOOK OF NORTH AMERICA
 
 
 
 
13.3
EUROPE
 
 
 
 
 
 
13.3.1
GERMANY
 
 
 
 
 
13.3.2
UK
 
 
 
 
 
13.3.3
FRANCE
 
 
 
 
 
13.3.4
SWITZERLAND
 
 
 
 
 
13.3.5
ITALY
 
 
 
 
 
13.3.6
SPAIN
 
 
 
 
 
13.3.7
REST OF EUROPE
 
 
 
 
 
13.3.8
MACROECONOMIC OUTLOOK OF EUROPE
 
 
 
 
13.4
ASIA PACIFIC
 
 
 
 
 
 
13.4.1
CHINA
 
 
 
 
 
13.4.2
JAPAN
 
 
 
 
 
13.4.3
INDIA
 
 
 
 
 
13.4.4
AUSTRALIA
 
 
 
 
 
13.4.5
SOUTH KOREA
 
 
 
 
 
13.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
13.4.7
MACROECONOMIC OUTLOOK OF ASIA PACIFIC
 
 
 
 
13.5
LATIN AMERICA
 
 
 
 
 
 
13.5.1
BRAZIL
 
 
 
 
 
13.5.2
MEXICO
 
 
 
 
 
13.5.3
REST OF LATIN AMERICA
 
 
 
 
 
13.5.4
MACROECONOMIC OUTLOOK OF LATIN AMERICA
 
 
 
 
13.6
MIDDLE EAST
 
 
 
 
 
 
13.6.1
GCC
 
 
 
 
 
 
13.6.1.1
UAE
 
 
 
 
 
13.6.1.2
SAUDI ARABIA
 
 
 
 
 
13.6.1.3
REST OF GCC
 
 
 
 
13.6.2
REST OF MIDDLE EAST
 
 
 
 
 
13.6.3
MACROECONOMIC OUTLOOK OF MIDDLE EAST
 
 
 
 
13.7
AFRICA
 
 
 
 
 
 
13.7.1
MACROECONOMIC OUTLOOK OF AFRICA
 
 
 
14
COMPETITIVE LANDSCAPE
 
 
 
 
 
 
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
 
 
 
 
 
 
 
14.1
INTRODUCTION
 
 
 
 
 
14.2
KEY PLAYERS STRATEGY/ RIGHT TO WIN
 
 
 
 
 
14.3
REVENUE ANALYSIS, 2022-2024
 
 
 
 
 
 
14.4
MARKET SHARE ANALYSIS,
 
 
 
 
 
 
14.5
COMPANY EVALUATION MATRIX: KEY PLAYERS
 
 
 
 
 
 
 
14.5.1
STARS
 
 
 
 
 
14.5.2
EMERGING LEADERS
 
 
 
 
 
14.5.3
PERVASIVE PLAYERS
 
 
 
 
 
14.5.4
PARTICIPANTS
 
 
 
 
 
14.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
 
14.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
14.5.5.2
REGION FOOTPRINT
 
 
 
 
 
14.5.5.3
PRODUCT FOOTPRINT
 
 
 
 
 
14.5.5.4
APPLICATION FOOTPRINT
 
 
 
14.6
COMPANY EVALUATION MATRIX: START-UPS/SMES,
 
 
 
 
 
 
 
14.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
14.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
14.6.3
DYNAMIC COMPANIES
 
 
 
 
 
14.6.4
STARTING BLOCKS
 
 
 
 
 
14.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
 
14.6.5.1
DETAILED LIST OF KEY STARTUPS/ SMES
 
 
 
 
 
14.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
 
 
 
14.7
COMPETITIVE SCENARIO
 
 
 
 
 
 
14.7.1
PRODUCT LAUNCHES
 
 
 
 
 
14.7.2
DEALS
 
 
 
 
 
14.7.3
OTHER DEVELOPMENTS
 
 
 
 
14.8
BRAND/ PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
 
14.9
VALUATION AND FINANCIAL METRICS
 
 
 
 
15
COMPANY PROFILES
 
 
 
 
 
 
15.1
KEY COMPANIES
 
 
 
 
 
 
15.1.1
THERMO FISHER SCIENTIFIC INC (US)
 
 
 
 
 
15.1.2
DANAHER CORPORATION (US)
 
 
 
 
 
15.1.3
AGILENT TECHNOLOGIES (US)
 
 
 
 
 
15.1.4
ILLUMINA (US)
 
 
 
 
 
15.1.5
MERCK KGAA (GERMANY)
 
 
 
 
 
15.1.6
QIAGEN (NETHERLANDS)
 
 
 
 
 
15.1.7
PERKINELMER, INC. (US)
 
 
 
 
 
15.1.8
WATERS CORPORATION (US)
 
 
 
16
RESEARCH METHODOLOGY
 
 
 
 
 
 
16.1
RESEARCH DATA
 
 
 
 
 
 
16.1.1
SECONDARY DATA
 
 
 
 
 
 
16.1.1.1
KEY SOURCES OF SECONDARY DATA
 
 
 
 
 
16.1.1.2
KEY OBJECTIVES OF SECONDARY DATA
 
 
 
 
16.1.2
PRIMARY DATA
 
 
 
 
 
 
16.1.2.1
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
16.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
 
 
 
16.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
16.2.1
PROTEIN MICROARRAY MARKET SIZE ESTIMATION
 
 
 
 
 
 
16.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
 
 
 
 
 
16.2.1.2
MNM REPOSITORY ANALYSIS
 
 
 
 
 
16.2.1.3
SECONDARY ANALYSIS
 
 
 
 
 
16.2.1.4
PRIMARY RESEARCH
 
 
 
 
 
 
16.2.1.4.1
INSIGHTS FROM PRIMARY EXPERTS
 
 
16.3
MARKET GROWTH RATE PROJECTIONS
 
 
 
 
 
16.4
DATA TRIANGULATION
 
 
 
 
 
16.6
RESEARCH ASSUMPTIONS
 
 
 
 
 
16.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
 
 
 
 
17
APPENDIX
 
 
 
 
 
 
17.1
DISCUSSION GUIDE
 
 
 
 
 
17.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
17.3
AVAILABLE CUSTOMIZATIONS
 
 
 
 
 
17.4
RELATED REPORTS
 
 
 
 
 
17.5
AUTHOR DETAILS
 
 
 
 

Methodology

This research involves the extensive use of secondary sources; directories; and databases (Bloomberg and Factiva) to identify and collect information useful for a technical, market-oriented, and commercial study of protein microarrays market. In-depth interviews were conducted with various primary respondents, such as key industry participants, Subject Matter Experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess prospects.

Secondary Research

In the secondary research process, various sources, such as the Food and Agricultural Organization (FAO), International Society for Horticulture Sciences (ISHS), Portuguese Association for Horticulture, Confederation of Horticulture Association of India, National Institute of Post-Harvest Technology, American Horticulture Society, Indian Academy of Horticulture Science (IAHS), International Association of Horticultural Producers (AIPH), Union Fleurs-International Flower Trade association, Floriculture International, European Association for Flower Growers, European Botanical and Horticultural Libraries Group (EBHL), were referred to identify and collect information for this study. The secondary sources also include journals, press releases, investor presentations of companies, whitepapers, certified publications, articles by recognized authors and regulatory bodies, trade directories, and paid databases.

Secondary research was conducted to obtain critical information about the industry’s supply chain, the total pool of key players, and market classification and segmentation according to the industry trends to the bottom-most level and geographical markets. It was also used to obtain information about the key developments from a market-oriented perspective.

Primary Research

The protein microarrays market comprises several stakeholders, including protein microarrays solution manufacturers and suppliers, agrochemical manufacturers, floriculture and horticulture organizations, and regulatory organizations in the supply chain. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Primary interviewees from the supply side include research institutions involved in R&D to introduce technology, protein microarrays solution distributors and wholesalers, importers & exporters of protein microarrays solution, protein microarrays solution manufacturers, and technology providers. Primary sources from the demand-side include key opinion leaders, executives, vice presidents, and CEOs of horticulture and floriculture companies through questionnaires, emails, and telephonic interviews.

 

To know about the assumptions considered for the study, download the pdf brochure

Protein Microarrays Market Size Estimation

Both the top-down and bottom-up approaches have been used to estimate and validate the total size of the protein microarrays market. These approaches were extensively used to determine the size of the subsegments in the market. The research methodology used to estimate the market size includes the following details:

Top-down approach:

  • The key industry and market players were identified through extensive secondary research.
  • The industry's supply chain and market size were determined through primary and secondary research.
  • All percentage share splits and breakdowns were determined using secondary sources and verified through primary sources.
  • The adjacent market—the crop protection market—was considered to validate further the market details of protein microarrays.

Bottom-up approach:

  • The market size was analyzed based on the share of each type of protein microarrays and its penetration within the crop type at regional and country levels. Thus, the global market was estimated with a bottom-up approach of the type at the country level.
  • Other factors include demand within the supply chain including floriculture and horticulture industry; and function trends; pricing trends; the adoption rate and price factors; patents registered; and organic and inorganic growth attempts.
  • All macroeconomic and microeconomic factors affecting protein microarrays market were considered while estimating the market size.
  • All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.

Data Triangulation

After arriving at the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to estimate the overall market and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.

Protein Microarrays Market Report Objectives

  • To define, segment, and project the global market for protein microarrays on the basis of type, nature, application and region 
  • To provide detailed information regarding the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micro markets with respect to individual growth trends, future prospects, and their contribution to the total market
  • To analyze the opportunities in the market for stakeholders and provide a competitive landscape of the market leaders.
  • To project the size of the market and its submarkets, in terms of value with respect to the regions (along with the key countries)
  • To strategically profile the key players and comprehensively analyze their market position and core competencies.
  • To analyze the competitive developments such as joint ventures, mergers & acquisitions, new product developments, and research & developments in the protein microarrays market

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

The following customization options are available for the report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolio of each company.

Geographic Analysis

With the given market data, MarketsandMarkets offers customizations according to the company-specific scientific needs.

  • Further breakdown of the Rest of European protein microarrays market, by key country
  • Further breakdown of the Rest of South America market, by key country

Company Information

  • Detailed analyses and profiling of additional market players

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Protein Microarrays Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Protein Microarrays Market

DMCA.com Protection Status